[Retracted] mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9

Figure 3

miR-126-5p targets ADAM9 to regulate cisplatin sensitivity in NSCLC: (a) ADAM9 mRNA harbors a miR-126-5p-binding sequence; (b) detection of luciferase activities of the reporter genes (); (c) qRT-PCR detected the mRNA expression of ADAM9 in sensitive and resistance groups (); (d) qRT-PCR detected the expression of ADAM9 in NSCLC cell lines (, ); (e) detection of ADAM9 mRNAs in the mimics group; (f) (left) western blotting-based detection of the protein expression in the mimics group and (right) quantitative analysis of the gray value of protein bands in the blot ( vs. NC group).

(a)

(b)

(c)

(d)

(e)

(f)